[HTML] nih.gov

[HTML][HTML] The BRAFV600E mutation: what is it really orchestrating in thyroid cancer?

C Nucera, J Lawler, R Hodin, S Parangi - Oncotarget, 2010 - ncbi.nlm.nih.gov
Abstract BRAF V600E is a constitutively active onco-kinase and is the most common genetic
alteration in papillary thyroid carcinoma (PTC), and in anaplastic thyroid carcinoma as well …
被引用次数：61 相关文章
[HTML] oncotarget.com

[HTML][HTML] The BRAFV600E mutation: what is it really orchestrating in thyroid cancer?

C Nucera, J Lawler, R Hodin, S Parangi - Oncotarget, 2010 - oncotarget.com
BRAFV600E is a constitutively active onco-kinase and is the most common genetic
alteration in papillary thyroid carcinoma (PTC), and in anaplastic thyroid carcinoma as well …
[HTML] nih.gov

[HTML][HTML] The BRAFV600E mutation: what is it really orchestrating in thyroid cancer?

C Nucera, J Lawler, R Hodin, S Parangi - Oncotarget, 2010 - ncbi.nlm.nih.gov
Abstract BRAF V600E is a constitutively active onco-kinase and is the most common genetic
alteration in papillary thyroid carcinoma (PTC), and in anaplastic thyroid carcinoma as well …

The BRAFV600E mutation: what is it really orchestrating in thyroid cancer?

C Nucera, J Lawler, R Hodin, S Parangi - Oncotarget, 2010 - europepmc.org
Abstract BRAF V600E is a constitutively active onco-kinase and is the most common genetic
alteration in papillary thyroid carcinoma (PTC), and in anaplastic thyroid carcinoma as well …
[PDF] academia.edu

[PDF][PDF] The BRAFV600E mutation: what is it really orchestrating in thyroid cancer?

C Nucera, J Lawler, R Hodin, S Parangi - academia.edu
brAFV600E is a constitutively active onco-kinase and is the most common genetic alteration
in papillary thyroid carcinoma (Ptc), and in anaplastic thyroid carcinoma as well, albeit at a …
[PDF] researchgate.net

[PDF][PDF] The BRAFV600E mutation: what is it really orchestrating in thyroid cancer?

C Nucera, J Lawler, R Hodin, S Parangi - researchgate.net
brAFV600E is a constitutively active onco-kinase and is the most common genetic alteration
in papillary thyroid carcinoma (Ptc), and in anaplastic thyroid carcinoma as well, albeit at a …
[PDF] archive.org

[PDF][PDF] The BRAFV600E mutation: what is it really orchestrating in thyroid cancer?

C Nucera, J Lawler, R Hodin, S Parangi - scholar.archive.org
brAFV600E is a constitutively active onco-kinase and is the most common genetic alteration
in papillary thyroid carcinoma (Ptc), and in anaplastic thyroid carcinoma as well, albeit at a …

The BRAFV600E mutation: what is it really orchestrating in thyroid cancer?

C Nucera, J Lawler, R Hodin, S Parangi - Oncotarget, 2010 - pubmed.ncbi.nlm.nih.gov
BRAFV600E is a constitutively active onco-kinase and is the most common genetic
alteration in papillary thyroid carcinoma (PTC), and in anaplastic thyroid carcinoma as well …
[PDF] scienceopen.com

[PDF][PDF] The BRAFV600E mutation: what is it really orchestrating in thyroid cancer?

C Nucera, J Lawler, R Hodin, S Parangi - scienceopen.com
brAFV600E is a constitutively active onco-kinase and is the most common genetic alteration
in papillary thyroid carcinoma (Ptc), and in anaplastic thyroid carcinoma as well, albeit at a …
[PDF] psu.edu

[PDF][PDF] The BRAFV600E mutation: what is it really orchestrating in thyroid cancer?

C Nucera, J Lawler, R Hodin, S Parangi - Citeseer
brAFV600E is a constitutively active onco-kinase and is the most common genetic alteration
in papillary thyroid carcinoma (Ptc), and in anaplastic thyroid carcinoma as well, albeit at a …